{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:52:27Z","timestamp":1785894747831,"version":"3.56.0"},"reference-count":182,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004385","name":"Ghent University","doi-asserted-by":"publisher","award":["BOF21\/DOC\/248"],"award-info":[{"award-number":["BOF21\/DOC\/248"]}],"id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004385","name":"Ghent University","doi-asserted-by":"publisher","award":["BOF23\/PDO\/073"],"award-info":[{"award-number":["BOF23\/PDO\/073"]}],"id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neuropharm.2026.111053","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:22:43Z","timestamp":1780118563000},"page":"111053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In vitro bioassays for measuring monoamine transporter function"],"prefix":"10.1016","volume":"298","author":[{"given":"Axelle","family":"Timmerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bosmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"Pottie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-348X","authenticated-orcid":false,"given":"Christophe","family":"Stove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neuropharm.2026.111053_bib1","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1016\/S0006-3495(02)75328-9","article-title":"Flux coupling in the human serotonin transporter","volume":"83","author":"Adams","year":"2002","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuropharm.2026.111053_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/cpph.32","article-title":"Overview of monoamine transporters","volume":"79","author":"Aggarwal","year":"2017","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111053_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/cpph.33","article-title":"In vitro assays for the functional characterization of the dopamine transporter (DAT)","volume":"79","author":"Aggarwal","year":"2017","journal-title":"Curr. Protoc. Pharmacol."},{"issue":"1986","key":"10.1016\/j.neuropharm.2026.111053_bib4","article-title":"All the brain's a stage for serotonin: the forgotten story of serotonin diffusion across cell membranes","volume":"289","author":"Andrews","year":"2022","journal-title":"Proceed. Biol. Sci."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111053_bib5","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111053_bib6","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/npp.2013.331","article-title":"Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates","volume":"39","author":"Baumann","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"46","key":"10.1016\/j.neuropharm.2026.111053_bib7","doi-asserted-by":"crossref","first-page":"15150","DOI":"10.1523\/JNEUROSCI.3223-14.2014","article-title":"Baths salts, spice, and related designer drugs: the science behind the headlines","volume":"34","author":"Baumann","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111053_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/164_2018_178","article-title":"Neuropharmacology of synthetic cathinones","volume":"252","author":"Baumann","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"issue":"23","key":"10.1016\/j.neuropharm.2026.111053_bib9","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.19-23-10494.1999","article-title":"Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level","volume":"19","author":"Benmansour","year":"1999","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111053_bib10","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1074\/jbc.274.8.4876","article-title":"Which form of dopamine is the substrate for the human dopamine transporter: the cationic or the uncharged species?","volume":"274","author":"Berfield","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111053_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neuropharm.2026.111053_bib12","series-title":"Handling of Intracellular K+ Determines Voltage Dependence of Plasmalemmal Monoamine Transporter Function","author":"Bhat","year":"2021"},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111053_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0165-6147(94)90315-8","article-title":"Current advances and trends in the treatment of depression","volume":"15","author":"Blier","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111053_bib14","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1111\/bph.13030","article-title":"Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues","volume":"172","author":"Bonano","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0304-3940(88)90670-2","article-title":"Distinguishing in vitro electrochemical signatures for norepinephrine and dopamine","volume":"95","author":"Broderick","year":"1988","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111053_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/bcpt.13940","article-title":"Development and validation of an automated microfluidic perfusion platform for parallelized screening of compounds in vitro","volume":"133","author":"Brugnoli","year":"2023","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2026.111053_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-anchem-071114-040426","article-title":"Electrochemical analysis of neurotransmitters","volume":"8","author":"Bucher","year":"2015","journal-title":"Annu. Rev. Anal. Chem."},{"issue":"28","key":"10.1016\/j.neuropharm.2026.111053_bib18","doi-asserted-by":"crossref","first-page":"11642","DOI":"10.1073\/pnas.1220552110","article-title":"Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate","volume":"110","author":"Buchmayer","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"26","key":"10.1016\/j.neuropharm.2026.111053_bib19","doi-asserted-by":"crossref","first-page":"12584","DOI":"10.1073\/pnas.91.26.12584","article-title":"Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium","volume":"91","author":"Buck","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib20","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1038\/s41598-024-56712-z","article-title":"5-HT_FAsTR: a versatile, label-free, high-throughput, fluorescence-based microplate assay to quantify serotonin transport and release","volume":"14","author":"Bukowski","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111053_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2020.105621","article-title":"A simple and efficient cyclic square wave voltammetric method for simultaneous determination of epinephrine and norepinephrine using an activated pencil graphite electrode","volume":"160","author":"Buleandr\u0103","year":"2021","journal-title":"Microchem. J."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111053_bib22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/bcpt.13827","article-title":"Illuminating the monoamine transporters: fluorescently labelled ligands to study dopamine, serotonin and norepinephrine transporters","volume":"133","author":"Camacho-Hernandez","year":"2023","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111053_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ceca.2015.06.013","article-title":"Amphetamine activates calcium channels through dopamine transporter-mediated depolarization","volume":"58","author":"Cameron","year":"2015","journal-title":"Cell Calcium"},{"issue":"24","key":"10.1016\/j.neuropharm.2026.111053_bib24","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.18-24-10257.1998","article-title":"Cocaine acts as an apparent competitive inhibitor at the outward-facing conformation of the human norepinephrine transporter: kinetic analysis of inward and outward transport","volume":"18","author":"Chen","year":"1998","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111053_bib25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41594-019-0253-7","article-title":"Monoamine transporters: structure, intrinsic dynamics and allosteric regulation","volume":"26","author":"Cheng","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111053_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.14302\/issn.2377-2549.jndc-20-3298","article-title":"Differential pulse voltammetry: evolution of an In vivo methodology and new chemical entries, A short review","volume":"2","author":"Crespi","year":"2020","journal-title":"J. New Develop.Chem."},{"issue":"14","key":"10.1016\/j.neuropharm.2026.111053_bib27","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1021\/acschemneuro.3c00156","article-title":"Structure\u2013Activity relationships for a recently controlled synthetic cathinone dopamine transporter reuptake inhibitor: \u03b1-Pyrrolidinohexiophenone (\u03b1-PHP)","volume":"14","author":"Davies","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111053_bib28","series-title":"High-Speed Chronoamperometry to Study Kinetics and Mechanisms for Serotonin Clearance in Vivo","author":"Daws","year":"2007"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111053_bib105","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0028-3908(89)90174-3","article-title":"Differences in the temperature dependence of drug interaction with the noradrenaline and serotonin transporters","volume":"28","author":"De Oliveira","year":"1989","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0014-2999(91)90309-E","article-title":"High-affinity binding of [3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion to mouse striatal membranes: putative vesicular location","volume":"202","author":"Del Zompo","year":"1991","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib181","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0006-8993(92)90677-2","article-title":"Characterization of a putatively vesicular binding site for [3H]MPP+ in mouse striatal membranes","volume":"571","author":"Del Zompo","year":"1992","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/acschembio.5b00753","article-title":"NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells","volume":"11","author":"Dixon","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111053_bib30","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/j.cell.2021.03.043","article-title":"Psychedelic-inspired drug discovery using an engineered biosensor","volume":"184","author":"Dong","year":"2021","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111053_bib31","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00216-024-05136-9","article-title":"Electrochemical and biosensor techniques to monitor neurotransmitter changes with depression","volume":"416","author":"Dunham","year":"2024","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.neuropharm.2026.111053_bib32","first-page":"12","article-title":"An overview of cell-based assay platforms for the solute carrier family of transporters","author":"Dvorak","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/abio.1998.2850","article-title":"Rotating disk electrode voltammetric measurements of dopamine transporter activity: an analytical evaluation","volume":"264","author":"Earles","year":"1998","journal-title":"Anal. Biochem."},{"issue":"44","key":"10.1016\/j.neuropharm.2026.111053_bib34","doi-asserted-by":"crossref","first-page":"10198","DOI":"10.1523\/JNEUROSCI.2460-05.2005","article-title":"Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains","volume":"25","author":"Eisensamer","year":"2005","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/syn.1076","article-title":"Binding characteristics of selective serotonin reuptake inhibitors with relation to emission tomography studies","volume":"41","author":"Elfving","year":"2001","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1021\/acs.jchemed.7b00361","article-title":"A practical beginner's guide to cyclic voltammetry","volume":"95","author":"Elgrishi","year":"2018","journal-title":"J. Chem. Educ."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111053_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201600240","article-title":"Proton electrochemical gradient: driving and regulating neurotransmitter uptake","volume":"39","author":"Farsi","year":"2017","journal-title":"Bioessays"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111053_bib38","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.neuron.2019.02.037","article-title":"A genetically encoded fluorescent sensor for rapid and specific in vivo detection of norepinephrine","volume":"102","author":"Feng","year":"2019","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111053_bib39","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/1087057106294698","article-title":"A nonradioactive high-throughput\/high-content assay for measurement of the human serotonin reuptake transporter function in vitro","volume":"11","author":"Fowler","year":"2006","journal-title":"J. Biomol. Screen"},{"issue":"16","key":"10.1016\/j.neuropharm.2026.111053_bib41","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1073\/pnas.93.16.8671","article-title":"Norepinephrine transporters have channel modes of conduction","volume":"93","author":"Galli","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111053_bib40","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1242\/jeb.198.10.2197","article-title":"Sodium-Dependent norepinephrine-induced currents in norepinephrine-transporter-transfected Hek-293 cells blocked by cocaine and antidepressants","volume":"198","author":"Galli","year":"1995","journal-title":"J. Exp. Biol."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111053_bib42","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/s41386-018-0209-3","article-title":"The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter","volume":"43","author":"Gannon","year":"2018","journal-title":"Neuropsychopharmacology : Off.Pub. Am College Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41467-023-44637-6","article-title":"Ligand coupling mechanism of the human serotonin transporter differentiates substrates from inhibitors","volume":"15","author":"Gradisch","year":"2024","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111053_bib44","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1074\/jbc.271.12.6911","article-title":"Ion coupling stoichiometry for the norepinephrine transporter in membrane vesicles from stably transfected cells (\u2217)","volume":"271","author":"Gu","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"5933","key":"10.1016\/j.neuropharm.2026.111053_bib45","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1126\/science.1172278","article-title":"Fluorescent false neurotransmitters visualize dopamine release from individual presynaptic terminals","volume":"324","author":"Gubernator","year":"2009","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneumeth.2010.08.009","article-title":"Rotating disk electrode voltammetric measurements of serotonin transporter kinetics in synaptosomes","volume":"193","author":"Hagan","year":"2010","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1527-3458.2004.tb00002.x","article-title":"The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile","volume":"10","author":"Haj\u00f3s","year":"2004","journal-title":"CNS Drug Rev."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111053_bib48","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nchembio.1545","article-title":"PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein","volume":"10","author":"Hamilton","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111053_bib49","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1471-4159.1985.tb05536.x","article-title":"Effects of monovalent ions on the transport of noradrenaline across the plasma membrane of neuronal cells (PC-12 cells)","volume":"45","author":"Harder","year":"1985","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib50","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/1087057107299524","article-title":"Pharmacological characterization of a fluorescent uptake assay for the noradrenaline transporter","volume":"12","author":"Hauns\u00f8","year":"2007","journal-title":"J. Biomol. Screen"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib51","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/ja00978a051","article-title":"Electrochemical studies of the oxidation pathways of catecholamines","volume":"89","author":"Hawley","year":"1967","journal-title":"J. Am. Chem. Soc."},{"issue":"5985","key":"10.1016\/j.neuropharm.2026.111053_bib52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/311467a0","article-title":"Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors","volume":"311","author":"Heikkila","year":"1984","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111053_bib53","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1021\/acschemneuro.7b00320","article-title":"Toward serotonin fluorescent false neurotransmitters: development of fluorescent dual serotonin and vesicular monoamine transporter substrates for visualizing serotonin neurons","volume":"9","author":"Henke","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111053_bib54","series-title":"Patch Clamp Electrophysiology: Methods and Protocols","first-page":"1","article-title":"An introduction to patch clamp recording","author":"Hill","year":"2021"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111053_bib55","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1021\/acs.analchem.6b00427","article-title":"Application of electrochemical redox cycling: toward differentiation of dopamine and norepinephrine","volume":"88","author":"Hu","year":"2016","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1039\/B807563H","article-title":"Carbon-fiber microelectrodes for in vivo applications","volume":"134","author":"Huffman","year":"2009","journal-title":"Analyst"},{"key":"10.1016\/j.neuropharm.2026.111053_bib57","series-title":"Physiology, Noradrenergic Synapse","author":"Hussain","year":"2025"},{"key":"10.1016\/j.neuropharm.2026.111053_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.144665","article-title":"Proposal for fluorescence-based in vitro assay using human and zebrafish monoamine transporters to detect biological activities of antidepressants in wastewater","volume":"770","author":"Ihara","year":"2021","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.neuropharm.2026.111053_bib59","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3389\/fphar.2020.00673","article-title":"Cell-Based radiotracer binding and uptake inhibition assays: a comparison of In vitro methods to assess the potency of drugs that target monoamine transporters","volume":"11","author":"Ilic","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111053_bib60","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nn920","article-title":"Dopamine transporter\u2013mediated conductances increase excitability of midbrain dopamine neurons","volume":"5","author":"Ingram","year":"2002","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0014-2999(84)90740-4","article-title":"Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP","volume":"106","author":"Javitch","year":"1984","journal-title":"Eur. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.neuropharm.2026.111053_bib62","doi-asserted-by":"crossref","first-page":"19315","DOI":"10.1074\/jbc.M311172200","article-title":"Regulated Internalization and Phosphorylation of the Native Norepinephrine Transporter in Response to Phorbol Esters: evidence for localization in lipid rafts and lipid raft-mediated internalization","volume":"279","author":"Jayanthi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111053_bib63","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jmgm.2017.07.003","article-title":"Molecular dynamics of conformation-specific dopamine transporter-inhibitor complexes","volume":"76","author":"Jean","year":"2017","journal-title":"J. Mol. Graph. Model."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111053_bib64","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.neuropharm.2007.03.004","article-title":"Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices","volume":"52","author":"John","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111053_bib65","series-title":"Fast Scan Cyclic Voltammetry of Dopamine and Serotonin in Mouse Brain Slices","author":"John","year":"2007"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111053_bib66","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jnc.12007","article-title":"Importance of cholesterol in dopamine transporter function","volume":"123","author":"Jones","year":"2012","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib67","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jneumeth.2007.12.004","article-title":"Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity","volume":"169","author":"J\u00f8rgensen","year":"2008","journal-title":"J. Neurosci. Methods"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111053_bib68","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/s41592-023-01959-z","article-title":"Sensitive multicolor indicators for monitoring norepinephrine in vivo","volume":"20","author":"Kagiampaki","year":"2023","journal-title":"Nat. Methods"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib69","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbrc.2011.07.087","article-title":"Impedance measurement: a new method to detect ligand-biased receptor signaling","volume":"412","author":"Kammermann","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111053_bib70","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1021\/cn400038u","article-title":"APP+, a fluorescent analogue of the Neurotoxin MPP+, is a marker of catecholamine neurons in brain tissue, but not a fluorescent false neurotransmitter","volume":"4","author":"Karpowicz","year":"2013","journal-title":"ACS Chem. Neurosci."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111053_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110903","article-title":"Prolintane analogs as hybrid monoamine transporter ligands: structural determinants and species differences","volume":"301","author":"Kastner","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib72","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0021-9258(19)68170-6","article-title":"Coupling of transmembrane proton gradients to platelet serotonin transport","volume":"257","author":"Keyes","year":"1982","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib73","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-8993(73)90503-9","article-title":"Voltammetry in brain tissue--a new neurophysiological measurement","volume":"55","author":"Kissinger","year":"1973","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111053_bib74","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev.pa.08.040168.002113","article-title":"False adrenergic transmitters","volume":"8","author":"Kopin","year":"1968","journal-title":"Annu. Rev. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib75","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","article-title":"SLC6 neurotransmitter transporters: structure, function, and regulation","volume":"63","author":"Kristensen","year":"2011","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib76","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1471-4159.1990.tb08847.x","article-title":"Kinetics and block of dopamine uptake in synaptosomes from Rat caudate nucleus","volume":"55","author":"Krueger","year":"1990","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib77","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0376-8716(99)00005-8","article-title":"Studies of selected phenyltropanes at monoamine transporters","volume":"56","author":"Kuhar","year":"1999","journal-title":"Drug Alcohol Depend."},{"issue":"19","key":"10.1016\/j.neuropharm.2026.111053_bib78","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1021\/ac301670h","article-title":"Ultrafast detection and quantification of brain signaling molecules with carbon fiber microelectrodes","volume":"84","author":"Lama","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neuropharm.2026.111053_bib79","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneumeth.2014.12.009","article-title":"Visualization of neurotransmitter uptake and release in serotonergic neurons","volume":"241","author":"Lau","year":"2015","journal-title":"J. Neurosci. Methods"},{"issue":"26","key":"10.1016\/j.neuropharm.2026.111053_bib80","doi-asserted-by":"crossref","first-page":"8828","DOI":"10.1021\/ja101740k","article-title":"Development of pH-Responsive fluorescent false neurotransmitters","volume":"132","author":"Lee","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"8025","key":"10.1016\/j.neuropharm.2026.111053_bib81","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41586-024-07796-0","article-title":"Dopamine reuptake and inhibitory mechanisms in human dopamine transporter","volume":"632","author":"Li","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111053_bib82","series-title":"Novel Psychoactive Substances","first-page":"109","article-title":"Chapter4 - pharmacological profiling of novel psychoactive substances","author":"Liechti","year":"2022"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111053_bib83","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/s41386-018-0133-6","article-title":"Regulation of monoamine transporters and receptors by lipid microdomains: implications for depression","volume":"43","author":"Liu","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib84","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1124\/mol.107.039800","article-title":"Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors","volume":"73","author":"Loland","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111053_bib85","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0896-6273(94)90337-9","article-title":"Conducting states of a mammalian serotonin transporter","volume":"12","author":"Mager","year":"1994","journal-title":"Neuron"},{"issue":"37","key":"10.1016\/j.neuropharm.2026.111053_bib86","doi-asserted-by":"crossref","first-page":"38770","DOI":"10.1074\/jbc.M400831200","article-title":"Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin","volume":"279","author":"Magnani","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111053_bib87","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1469-8749.2008.03027.x","article-title":"Serotonin and dopamine transporter binding in children with autism determined by SPECT","volume":"50","author":"Makkonen","year":"2008","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neuropharm.2026.111053_bib88","article-title":"Micro- and nano-electrodes for neurotransmitter monitoring","volume":"29","author":"Marinesco","year":"2021","journal-title":"Curr. Opin. Electrochem."},{"issue":"5985","key":"10.1016\/j.neuropharm.2026.111053_bib89","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/311464a0","article-title":"Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism","volume":"311","author":"Markey","year":"1984","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib90","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneumeth.2004.09.028","article-title":"Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation","volume":"143","author":"Mason","year":"2005","journal-title":"J. Neurosci. Methods"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111053_bib91","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1021\/acschemneuro.5b00219","article-title":"Differential uptake mechanisms of fluorescent substrates into stem-cell-derived serotonergic neurons","volume":"6","author":"Matthaeus","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111053_bib92","series-title":"Neuropharmacology of New Psychoactive Substances (NPS): the Science Behind the Headlines","first-page":"333","article-title":"Application of a combined approach to identify new psychoactive street drugs and decipher their mechanisms at monoamine transporters","author":"Mayer","year":"2017"},{"key":"10.1016\/j.neuropharm.2026.111053_bib93","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/7854_2016_63","article-title":"Application of a combined approach to identify new psychoactive street drugs and decipher their mechanisms at monoamine transporters","volume":"32","author":"Mayer","year":"2017","journal-title":"Curr Top Behav.Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111053_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109704","article-title":"Mephedrone induces partial release at human dopamine transporters but full release at human serotonin transporters","volume":"240","author":"Mayer","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111053_bib95","series-title":"Chemical Biology of Neurodegeneration","first-page":"227","article-title":"Metabolism of neurotransmitters","author":"Merino","year":"2019"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib96","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0731-7085(98)00145-9","article-title":"Electrochemical monitoring of biogenic amine neurotransmission in real time","volume":"19","author":"Michael","year":"1999","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib97","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib98","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1124\/jpet.118.250902","article-title":"Interactions between cocaine and the putative allosteric dopamine transporter ligand SRI-31142","volume":"367","author":"Moerke","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111053_bib99","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1387-2656(05)11007-2","article-title":"Cell and tissue autofluorescence research and diagnostic applications","volume":"11","author":"Monici","year":"2005","journal-title":"Biotechnol. Annu. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1523\/JNEUROSCI.22-02-00389.2002","article-title":"Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines","volume":"22","author":"Mor\u00f3n","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111053_bib101","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1242\/jeb.196.1.213","article-title":"Porters and neurotransmitter transporters","volume":"196","author":"Nelson","year":"1994","journal-title":"J. Exp. Biol."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111053_bib102","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1016\/S0021-9258(20)65119-5","article-title":"The role of chloride ion in platelet serotonin transport","volume":"257","author":"Nelson","year":"1982","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib103","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/j.1875-9114.1994.tb02799.x","article-title":"The clinical pharmacology and use of paroxetine, a new selective serotonin reuptake inhibitor","volume":"14","author":"Nemeroff","year":"1994","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib104","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0301-0082(02)00011-4","article-title":"Dopamine and the regulation of cognition and attention","volume":"67","author":"Nieoullon","year":"2002","journal-title":"Prog. Neurobiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111053_bib106","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1471-4159.2010.06828.x","article-title":"Real-time, spatially resolved analysis of serotonin transporter activity and regulation using the fluorescent substrate, ASP+","volume":"114","author":"Oz","year":"2010","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib108","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-3565(24)34961-4","article-title":"Comparison of the pharmacological properties of cloned Rat, human, and bovine norepinephrine Transporters1","volume":"290","author":"Paczkowski","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111053_bib109","series-title":"Neurotransmitter Transporters: Investigative Methods","first-page":"41","article-title":"Interrogating the activity of ligands at monoamine transporters in Rat Brain synaptosomes","author":"Partilla","year":"2016"},{"issue":"6396","key":"10.1016\/j.neuropharm.2026.111053_bib110","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat4422","article-title":"Ultrafast neuronal imaging of dopamine dynamics with designed genetically encoded sensors","volume":"360","author":"Patriarchi","year":"2018","journal-title":"Science (New York, N.Y.)"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111053_bib111","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nn.4252","article-title":"Fluorescent false neurotransmitter reveals functionally silent dopamine vesicle clusters in the striatum","volume":"19","author":"Pereira","year":"2016","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib112","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1021\/ac049103g","article-title":"Chronoamperometry to determine differential reductions in uptake in brain synaptosomes from serotonin transporter knockout mice","volume":"77","author":"Perez","year":"2005","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neuropharm.2026.111053_bib113","article-title":"Characterization of neurotransmitter inhibition for seven cathinones by a proprietary fluorescent dye method","author":"Persson","year":"2023","journal-title":"Drug Test. Anal."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib114","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.bjp.0701137","article-title":"Induction by low Na+ or Cl- of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human catecholamine transporters","volume":"121","author":"Pifl","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111053_bib115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2015.03.004","article-title":"The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter","volume":"755","author":"Pifl","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111053_bib117","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1007\/s00204-020-02836-w","article-title":"In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of \u03b2-arrestin 2 recruitment to the serotonin 2A receptor","volume":"94","author":"Pottie","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"24","key":"10.1016\/j.neuropharm.2026.111053_bib116","doi-asserted-by":"crossref","first-page":"15444","DOI":"10.1021\/acs.analchem.9b03104","volume":"91","author":"Pottie","year":"2019","journal-title":"Anal. Chem."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111053_bib118","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1039\/C9AN01925A","article-title":"Recent advances in fast-scan cyclic voltammetry","volume":"145","author":"Puthongkham","year":"2020","journal-title":"Analyst"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib119","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.pharmthera.2010.09.009","article-title":"Regulation of monoamine transporters: role of transporter phosphorylation","volume":"129","author":"Ramamoorthy","year":"2011","journal-title":"Pharmacol. Therapeut."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib120","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1021\/acs.analchem.7b04732","article-title":"Fast-Scan cyclic voltammetry: Chemical sensing in the brain and beyond","volume":"90","author":"Roberts","year":"2018","journal-title":"Anal. Chem."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111053_bib121","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1373\/49.10.1763","article-title":"Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo","volume":"49","author":"Robinson","year":"2003","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib122","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/acschemneuro.6b00393","article-title":"Hitchhiker's guide to voltammetry: acute and chronic electrodes for in vivo fast-scan Cyclic voltammetry","volume":"8","author":"Rodeberg","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib123","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1124\/jpet.103.048751","article-title":"Distinct recognition of substrates by the Human and Drosophila serotonin transporters","volume":"306","author":"Rodr\u00edguez","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib124","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1073\/pnas.1213569110","article-title":"Fluorescent dopamine tracer resolves individual dopaminergic synapses and their activity in the brain","volume":"110","author":"Rodriguez","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2026.111053_bib125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","article-title":"Monoamine transporters and psychostimulant drugs","volume":"479","author":"Rothman","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111053_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115513","article-title":"Functional characterization of N-octyl 4-methylamphetamine variants and related bivalent compounds at the dopamine and serotonin transporters using Ca2+ channels as sensors","volume":"419","author":"Ruchala","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ceca.2014.04.003","article-title":"Electrical coupling between the human serotonin transporter and voltage-gated Ca2+ channels","volume":"56","author":"Ruchala","year":"2014","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neuropharm.2026.111053_bib128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0076-6879(98)96018-9","article-title":"[16] ion-coupled neurotransmitter transport: thermodynamic vs. kinetic determinations of stoichiometry","volume":"296","author":"Rudnick","year":"1998","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2020.09.036","article-title":"Imaging neurotransmitter and neuromodulator dynamics in vivo with genetically encoded indicators","volume":"108","author":"Sabatini","year":"2020","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111053_bib130","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/npp.2014.325","article-title":"'Second-generation' mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function","volume":"40","author":"Saha","year":"2015","journal-title":"Neuropsychopharmacology : Off. Pub.Am College Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib131","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neulet.2003.10.032","article-title":"Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake","volume":"354","author":"Salda\u00f1a","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"35","key":"10.1016\/j.neuropharm.2026.111053_bib132","doi-asserted-by":"crossref","first-page":"10507","DOI":"10.1021\/bi010730z","article-title":"Membrane cholesterol modulates serotonin transporter activity","volume":"40","author":"Scanlon","year":"2001","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib133","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneumeth.2004.09.021","article-title":"Unraveling neuronal dopamine transporter mechanisms with rotating disk electrode voltammetry","volume":"143","author":"Schenk","year":"2005","journal-title":"J. Neurosci. Methods"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111053_bib134","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00213-015-4057-0","article-title":"Reinforcing and neurochemical effects of the \"bath salts\" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats","volume":"233","author":"Schindler","year":"2016","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib136","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(01)02058-4","article-title":"Substantial loss of substrate by diffusion during uptake in HEK-293 cells expressing neurotransmitter transporters","volume":"309","author":"Scholze","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib135","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0022-3565(24)39309-7","article-title":"Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter","volume":"293","author":"Scholze","year":"2000","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111053_bib137","doi-asserted-by":"crossref","first-page":"9768","DOI":"10.1074\/jbc.M209824200","article-title":"Binding and transport in norepinephrine transporters. Real-time, spatially resolved analysis in single cells using a fluorescent substrate","volume":"278","author":"Schwartz","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.neuropharm.2026.111053_bib138","doi-asserted-by":"crossref","first-page":"19177","DOI":"10.1074\/jbc.M412923200","article-title":"Substrate binding stoichiometry and kinetics of the norepinephrine transporter","volume":"280","author":"Schwartz","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib139","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgad044","article-title":"Computational models of dopamine release measured by fast scan cyclic voltammetry in vivo","volume":"2","author":"Shashaank","year":"2023","journal-title":"PNAS Nexus"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111053_bib142","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tips.2022.02.004","article-title":"Targeting solute carriers to modulate receptor-ligand interactions","volume":"43","author":"Sijben","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib140","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41598-020-79218-w","article-title":"A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery","volume":"11","author":"Sijben","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib141","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91700-7","article-title":"Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET\/SLC6A2) inhibitors","volume":"11","author":"Sijben","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111053_bib143","series-title":"Assay Guidance Manual","article-title":"Interference with fluorescence and absorbance","author":"Simeonov","year":"2004"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib146","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1046\/j.1471-4159.2000.741317.x","article-title":"Characterization of carrier-mediated efflux in human embryonic kidney 293 cells stably expressing the rat serotonin transporter: a superfusion study","volume":"74","author":"Sitte","year":"2000","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib144","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1471-4159.2009.06474.x","article-title":"The reverse operation of Na(+)\/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango","volume":"112","author":"Sitte","year":"2010","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2014.11.006","article-title":"Amphetamines, new psychoactive drugs and the monoamine transporter cycle","volume":"36","author":"Sitte","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111053_bib148","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/npp.2017.98","article-title":"N-Alkylated analogs of 4-Methylamphetamine (4-MA) differentially affect monoamine transporters and abuse liability","volume":"42","author":"Solis","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111053_bib147","doi-asserted-by":"crossref","first-page":"8852","DOI":"10.1074\/jbc.M111.267757","article-title":"4-(4-(dimethylamino)phenyl)-1-methylpyridinium (APP+) is a fluorescent substrate for the human serotonin transporter","volume":"287","author":"Solis","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib150","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1523\/JNEUROSCI.17-03-00960.1997","article-title":"Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants","volume":"17","author":"Sonders","year":"1997","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib149","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0959-4388(96)80111-5","article-title":"Channels in transporters","volume":"6","author":"Sonders","year":"1996","journal-title":"Curr. Opin. Neurobiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib151","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00213-018-5103-5","article-title":"Using Ca2+-channel biosensors to profile amphetamines and cathinones at monoamine transporters: electro-engineering cells to detect potential new psychoactive substances","volume":"236","author":"Steele","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111053_bib152","series-title":"Neurotransmitter Transporters: Investigative Methods","first-page":"23","article-title":"Tracer flux measurements to Study outward transport by monoamine neurotransmitter transporters","author":"Steinkellner","year":"2016"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111053_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105063","article-title":"Amphetamine-induced reverse transport of dopamine does not require cytosolic Ca2+","volume":"299","author":"St\u00f8ier","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111053_bib154","series-title":"Neurotransmitter Transporters: Investigative Methods","first-page":"1","article-title":"Classical radioligand uptake and binding methods in transporter research: an emphasis on the monoamine neurotransmitter transporters","author":"Sucic","year":"2016"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111053_bib155","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: a review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib156","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2018.06.042","article-title":"A genetically encoded fluorescent sensor enables rapid and specific detection of dopamine in flies, fish, and mice","volume":"174","author":"Sun","year":"2018","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111053_bib157","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1016\/S0021-9258(18)32380-9","article-title":"The serotonin transporter-imipramine \"receptor\"","volume":"258","author":"Talvenheimo","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111053_bib158","doi-asserted-by":"crossref","DOI":"10.3390\/mi12020208","article-title":"Recent advances in in vivo neurochemical monitoring","volume":"12","author":"Tan","year":"2021","journal-title":"Micromachines"},{"issue":"32","key":"10.1016\/j.neuropharm.2026.111053_bib159","doi-asserted-by":"crossref","first-page":"17872","DOI":"10.1021\/acs.analchem.5c03836","article-title":"Setup and evaluation of the TRACT assay principle for the In vitro functional characterization of modulators of the serotonin transporter and the serotonin 2A receptor","author":"Timmerman","year":"2025","journal-title":"Anal. Chem."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111053_bib160","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1021\/ac4008682","article-title":"Single cell amperometry reveals glycocalyx hinders the release of neurotransmitters during exocytosis","volume":"85","author":"Trouillon","year":"2013","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib161","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.vascn.2009.12.003","article-title":"Influence of ligand binding kinetics on functional inhibition of human recombinant serotonin and norepinephrine transporters","volume":"61","author":"Tsuruda","year":"2010","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib162","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2006.11.018","article-title":"Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter","volume":"1131","author":"Ukairo","year":"2007","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111053_bib163","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.cell.2020.11.040","article-title":"Directed evolution of a selective and sensitive serotonin sensor via machine learning","volume":"183","author":"Unger","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.111053_bib164","unstructured":"UNODC Early Warning Advisory on New Psychoactive Substances. Pharmacology: Stimulants. https:\/\/www.unodc.org\/LSS\/Page\/NPS\/pharmacology\/Stimulants (accessed 10\/December\/2025)."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111053_bib165","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1039\/C9AN01586H","article-title":"Fundamentals of fast-scan cyclic voltammetry for dopamine detection","volume":"145","author":"Venton","year":"2020","journal-title":"Analyst"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib166","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48829-3","article-title":"Label-free detection of transporter activity via GPCR signalling in living cells: a case for SLC29A1, the equilibrative nucleoside transporter 1","volume":"9","author":"Vlachodimou","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib167","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/1087057106297994","article-title":"High-throughput screening for norepinephrine transporter inhibitors using the FLIPRTetra","volume":"12","author":"Wagstaff","year":"2007","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.neuropharm.2026.111053_bib168","article-title":"A genetically encoded GRAB sensor for measuring serotonin dynamics","volume":"2020","author":"Wan","year":"2020","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111053_bib169","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1046\/j.1471-4159.1998.70051941.x","article-title":"Relationships between the catechol substrate binding site and amphetamine, cocaine, and Mazindol binding sites in a kinetic model of the striatal transporter of dopamine in vitro","volume":"70","author":"Wayment","year":"1998","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111053_bib170","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1124\/jpet.104.080101","article-title":"Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs","volume":"313","author":"Wee","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111053_bib171","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4161\/chan.2.5.6896","article-title":"Technologies for transporter drug discovery","volume":"2","author":"Weinglass","year":"2008","journal-title":"Channels"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111053_bib172","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1360-0443.2011.03502.x","article-title":"Mephedrone: use, subjective effects and health risks","volume":"106","author":"Winstock","year":"2011","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111053_bib173","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrn1406","article-title":"Dopamine, learning and motivation","volume":"5","author":"Wise","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"20","key":"10.1016\/j.neuropharm.2026.111053_bib174","doi-asserted-by":"crossref","first-page":"7838","DOI":"10.1523\/JNEUROSCI.20-20-07838.2000","article-title":"Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity","volume":"20","author":"Xie","year":"2000","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111053_bib175","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1021\/acschemneuro.9b00284","article-title":"Synthetic cathinone analogues structurally related to the central stimulant methylphenidate as dopamine reuptake inhibitors","volume":"10","author":"Yadav-Samudrala","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111053_bib176","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cobme.2019.09.010","article-title":"New optical methods for detecting monoamine neuromodulators","volume":"12","author":"Zeng","year":"2019","journal-title":"Current Opinion Biomed.Eng."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111053_bib107","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1038\/s41380-024-02608-3","article-title":"Mechanisms of neuromodulatory volume transmission","volume":"29","author":"\u00d6z\u00e7ete","year":"2024","journal-title":"Mol. Psychiatr."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111053_bib177","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.apsb.2012.03.006","article-title":"Quality control of cell-based high-throughput drug screening","volume":"2","author":"Zhang","year":"2012","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111053_bib179","first-page":"1","article-title":"Patch clamp technique: review of the current state of the art and potential contributions from nanoengineering","volume":"222","author":"Zhao","year":"2008","journal-title":"Proc. Inst. Mech. Eng. - Part N J. Nanoeng. Nanosyst."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111053_bib178","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/jnc.15865","article-title":"Techniques for in vivo serotonin detection in the brain: state of the art","volume":"166","author":"Zhao","year":"2023","journal-title":"J. Neurochem."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2026.111053_bib182","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tiv.2017.05.010","article-title":"Measuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay","volume":"45","author":"Zwartsen","year":"2017","journal-title":"Toxicol. Vitro"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:33:16Z","timestamp":1785893596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826002273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":182,"alternative-id":["S0028390826002273"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111053","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro bioassays for measuring monoamine transporter function","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111053"}}